Health
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages – News-Medical.Net
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses…
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The researchers from CureVac AG in Tübingen and the Friedrich-Loeffler-Institute in Greifswald-Insel Riems say that compared with their previous vaccine candidate – CvnCoV – the second-generation CV2CoV vaccine accelerated induction of neutralizing antibody titers…
-
Noosa News23 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General19 hours agoDairy farmers devastated by floods across parts of New South Wales